MBC Pharma (United States)

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Howard L. Kaufman, Michael B. Atkins, Prasun Subedi et al. · Journal for ImmunoTherapy of Cancer · 2019 · 111 citations · Full text

Colorado Medical Students’ Attitudes and Beliefs About Marijuana

Michael Chan, Christopher E. Knoepke, Madeline L. Cole et al. · Journal of General Internal Medicine · 2017 · 78 citations · Full text

Cannabis Use, Substance Abuse, Substance Use +7

Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes

Alan B. Kochman, Dale H. Carnegie, Thomas J. Burke · Journal of the American Podiatric Medical Association · 2002 · 62 citations

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

Hua Yang, Elizabeth Merica, Yue Chen et al. · Clinical Pharmacology in Drug Development · 2018 · 51 citations

A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites

Monica M. Reinholz, Shawn Zinnen, Amylou C. Dueck et al. · Bone · 2010 · 39 citations

Bone Disease, Promising Approach, Tumor-induced Bone Diseases +12